First Trust Advisors’s Biogen BIIB Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q1 | $124M | Buy |
673,958
+108,111
| +19% | +$19.9M | 0.09% | 284 |
|
|
2025
Q4 | $99.6M | Sell |
565,847
-274,710
| -33% | -$44.9M | 0.07% | 332 |
|
|
2025
Q3 | $118M | Sell |
840,557
-33,266
| -4% | -$4.5M | 0.09% | 274 |
|
|
2025
Q2 | $110M | Buy |
873,823
+212,403
| +32% | +$26.5M | 0.09% | 276 |
|
|
2025
Q1 | $90.5M | Buy |
661,420
+150,140
| +29% | +$21.5M | 0.08% | 304 |
|
|
2024
Q4 | $78.2M | Buy |
511,280
+152,789
| +43% | +$25.8M | 0.07% | 362 |
|
|
2024
Q3 | $69.5M | Sell |
358,491
-31,460
| -8% | -$6.58M | 0.07% | 359 |
|
|
2024
Q2 | $90.4M | Buy |
389,951
+55,655
| +17% | +$12.1M | 0.09% | 238 |
|
|
2024
Q1 | $72.1M | Sell |
334,296
-643,012
| -66% | -$151M | 0.07% | 328 |
|
|
2023
Q4 | $253M | Buy |
977,308
+571,795
| +141% | +$140M | 0.28% | 84 |
|
|
2023
Q3 | $104M | Sell |
405,513
-6,186
| -2% | -$1.65M | 0.12% | 204 |
|
|
2023
Q2 | $117M | Buy |
411,699
+26,107
| +7% | +$7.77M | 0.13% | 188 |
|
|
2023
Q1 | $107M | Buy |
385,592
+110,309
| +40% | +$30.5M | 0.12% | 207 |
|
|
2022
Q4 | $76.2M | Sell |
275,283
-113,693
| -29% | -$32.1M | 0.09% | 333 |
|
|
2022
Q3 | $104M | Sell |
388,976
-50,425
| -11% | -$10.7M | 0.13% | 189 |
|
|
2022
Q2 | $89.6M | Buy |
439,401
+41,880
| +11% | +$8.56M | 0.11% | 251 |
|
|
2022
Q1 | $83.7M | Buy |
397,521
+52,172
| +15% | +$11.3M | 0.09% | 313 |
|
|
2021
Q4 | $82.9M | Buy |
345,349
+16,541
| +5% | +$4.25M | 0.08% | 306 |
|
|
2021
Q3 | $93M | Sell |
328,808
-103,298
| -24% | -$33.9M | 0.1% | 253 |
|
|
2021
Q2 | $150M | Buy |
432,106
+10,447
| +2% | +$3.16M | 0.16% | 154 |
|
|
2021
Q1 | $118M | Buy |
421,659
+8,441
| +2% | +$2.28M | 0.14% | 180 |
|
|
2020
Q4 | $101M | Sell |
413,218
-20,223
| -5% | -$5.22M | 0.13% | 188 |
|
|
2020
Q3 | $123M | Buy |
433,441
+35,775
| +9% | +$9.98M | 0.2% | 123 |
|
|
2020
Q2 | $106M | Sell |
397,666
-82,922
| -17% | -$24.9M | 0.18% | 128 |
|
|
2020
Q1 | $152M | Sell |
480,588
-61,835
| -11% | -$18.8M | 0.34% | 43 |
|
|
2019
Q4 | $161M | Buy |
542,423
+118,511
| +28% | +$32.9M | 0.27% | 59 |
|
|
2019
Q3 | $98.7M | Sell |
423,912
-154,494
| -27% | -$36M | 0.19% | 115 |
|
|
2019
Q2 | $135M | Buy |
578,406
+171,855
| +42% | +$39.7M | 0.26% | 65 |
|
|
2019
Q1 | $96.1M | Buy |
406,551
+24,735
| +6% | +$7.79M | 0.19% | 129 |
|
|
2018
Q4 | $115M | Buy |
381,816
+40,357
| +12% | +$12.9M | 0.27% | 59 |
|
|
2018
Q3 | $121M | Buy |
341,459
+85,505
| +33% | +$29.4M | 0.22% | 85 |
|
|
2018
Q2 | $74.3M | Buy |
255,954
+20,608
| +9% | +$5.79M | 0.15% | 134 |
|
|
2018
Q1 | $64.4M | Buy |
235,346
+26,001
| +12% | +$8.07M | 0.15% | 132 |
|
|
2017
Q4 | $66.7M | Sell |
209,345
-12,815
| -6% | -$4.11M | 0.16% | 122 |
|
|
2017
Q3 | $69.6M | Buy |
222,160
+75,195
| +51% | +$22.3M | 0.18% | 118 |
|
|
2017
Q2 | $39.9M | Sell |
146,965
-13,096
| -8% | -$3.46M | 0.11% | 220 |
|
|
2017
Q1 | $43.8M | Sell |
160,061
-39,000
| -20% | -$11M | 0.12% | 173 |
|
|
2016
Q4 | $56.5M | Buy |
199,061
+72,833
| +58% | +$21.6M | 0.17% | 114 |
|
|
2016
Q3 | $39.5M | Sell |
126,228
-7,888
| -6% | -$2.34M | 0.12% | 189 |
|
|
2016
Q2 | $32.4M | Sell |
134,116
-3,029
| -2% | -$798K | 0.1% | 230 |
|
|
2016
Q1 | $35.7M | Sell |
137,145
-271,686
| -66% | -$71.8M | 0.11% | 205 |
|
|
2015
Q4 | $125M | Sell |
408,831
-49,469
| -11% | -$14.2M | 0.33% | 53 |
|
|
2015
Q3 | $134M | Sell |
458,300
-50,433
| -10% | -$16.7M | 0.39% | 32 |
|
|
2015
Q2 | $205M | Buy |
508,733
+166,858
| +49% | +$67M | 0.53% | 16 |
|
|
2015
Q1 | $144M | Sell |
341,875
-41,881
| -11% | -$16.5M | 0.42% | 31 |
|
|
2014
Q4 | $130M | Buy |
383,756
+19,583
| +5% | +$6.34M | 0.44% | 17 |
|
|
2014
Q3 | $120M | Buy |
364,173
+10,672
| +3% | +$3.52M | 0.47% | 13 |
|
|
2014
Q2 | $111M | Buy |
353,501
+2,622
| +0.7% | +$789K | 0.46% | 11 |
|
|
2014
Q1 | $107M | Buy |
350,879
+83,087
| +31% | +$26.4M | 0.47% | 14 |
|
|
2013
Q4 | $74.9M | Sell |
267,792
-23,575
| -8% | -$6.1M | 0.36% | 25 |
|
|
2013
Q3 | $70.2M | Buy |
291,367
+50,000
| +21% | +$11.2M | 0.38% | 29 |
|
|
2013
Q2 | $51.9M | Buy |
+241,367
| New | +$51.6M | 0.34% | 34 |
|
Other funds holding BIIB
VCM
VPM
First Trust Advisors's BIIB Position: Q1 2026 in Review
First Trust Advisors increased its Biogen (BIIB) stake by 19% in Q1 2026, buying an estimated $19.9M and bringing the position to 673,958 shares worth $124M. The position accounts for 0.09% of the portfolio, ranked #284.
First Trust Advisors first reported a position in BIIB in Q2 2013 and has held it in 52 quarters since. The position peaked at $253M in Q4 2023. 1,002 funds tracked by Wall St. Rank hold BIIB as of Q1 2026.
- First Trust Advisors held 673,958 shares of Biogen worth $124M as of Q1 2026.
- First Trust Advisors bought 108,111 Biogen shares in Q1 2026, an estimated $19.9M.
- Biogen made up 0.09% of First Trust Advisors's portfolio in Q1 2026, its #284 holding.
- First Trust Advisors first reported a position in Biogen in Q2 2013 and has held it in 52 quarters since.
- First Trust Advisors's Biogen position peaked at $253M in Q4 2023.
- 1,002 funds tracked by Wall St. Rank held Biogen as of Q1 2026.
Based on First Trust Advisors's 13F filing for Q1 2026, filed 13 May 2026.